NDC 23155-244-22 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 23155-244
- Requested NDC
- 23155-244-22
- Package NDCs from labels
- 23155-244-22, 23155-244-45, 23155-244-46
- Manufacturer
- Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited
- Effective date
- 2019-10-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RIZATRIPTAN - Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited | Heritage Pharmaceuticals Inc. | Emcure Pharmaceuticals Limited | 2019-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-244-22 | EA - Each | 23155-244 | 828359cf-ecc9-40d1-b5cd-c99059b64fa6 | 1 | 2019-07-02 |
| 23155-244-46 | EA - Each | 23155-244 | bafdbe0b-7f45-42aa-8756-b37c3f65c235 | 1 | 2014-10-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN BENZOATE TABLET [HERITAGE PHARMACEUTICALS INC.] | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine | CALAMINE | AMERISOURCE BERGEN | 90d9d908-57ea-4062-ade0-8a4888939c91 | 2026-01-29 | Warnings, Adverse reactions | 1K09F3G675 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| First Chakra (Root) 7301 | FIRST CHAKRA (ROOT) | Professional Complementary Health Formulas | 61eb1bbe-6675-4369-b852-18975e6b08c7 | 2026-01-08 | Warnings | 1K09F3G675 |
| Third Chakra (Solar Plexus) 7303 | THIRD CHAKRA (SOLAR PLEXUS) | Professional Complementary Health Formulas | eea89c37-ab87-4cc7-8dfc-e7f42a580dd9 | 2026-01-08 | Warnings | 1K09F3G675 |
| Dermagesic | PRAMOXINE HCL, ZINC OXIDE, CALAMINE | Llorens Pharmaceutical International Division | bbff6b53-29da-45c1-8ccd-3e9df7f250e0 | 2025-12-31 | Warnings | 1K09F3G675 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| BABY ANTI MONKEY BUTT DIAPER RASH | ZINC OXIDE, CALAMINE | Clarion Brands, LLC | e4424d74-f89c-5943-42e8-bf3a38e68619 | 2025-12-23 | Warnings | 1K09F3G675 |
| Rizatriptan | RIZATRIPTAN | Bryant Ranch Prepack | f000d96c-42a0-4aac-96ca-8cef289979ce | 2025-11-26 | Warnings, Adverse reactions | WR978S7QHH |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Kroger Co. | 6b3e7aac-395f-48cf-9c5e-f7e163724aef | 2025-11-17 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2025-11-17 | Warnings | 1K09F3G675 |
| Au Kah Chuen Fugical | CALAMINE AND DIPHENHYDRAMINE HYDROCHLORID | Zhejiang Dingtai Pharmaceutical Co., Ltd | 5b4add17-6c3d-4093-826a-2edb41c1d1db | 2025-11-10 | Warnings | 1K09F3G675 |
| FARGELIN HEMORRHOIDAL | CALAMINE, PETROLATUM AND PHENYLEPHRINE HYDROCHLORIDE | MADISON ONE ACME INC | 6844ad63-512d-496a-9458-011894185b0d | 2025-11-10 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2025-11-06 | Warnings | 1K09F3G675 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 6391d2a1-252e-4e50-9d80-4dce12eabc8f | 2025-11-06 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 187204ef-5370-476a-84b1-e3c54b60c6c2 | 2025-11-06 | Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan | RIZATRIPTAN | A-S Medication Solutions | 34395ed2-97b7-4220-9089-0e90169d3083 | 2025-11-05 | Warnings, Adverse reactions | WR978S7QHH |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2025-11-03 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2025-10-30 | Warnings | 1K09F3G675 |
| REMEDY Calazime Skin Protectant | CALAMINE, MENTHOL, WHITE PETROLATUM, ZINC OXIDE | Medline Industries, LP | 1295cfcc-5b61-481b-964b-f53ffd0cb58e | 2025-10-30 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2025-10-30 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.